News The Startup Connection: Researchers and Business Students Meet at Fall Collaboratorium Connecting researchers with business expertise, the Fall 2023 Collaboratorium will feature teams participating in the Polsky I-Corps program in addition to startups from the Transform and Duality accelerators. The Collaboratorium provides the opportunity for...
News 22 Teams From Across Campus Explore Commercial Potential of New Ideas More than 20 teams participated in the Polsky Center I-Corps program this academic year – all with new research and ideas addressing challenges across various industries. The goal of the...
News 10 Teams Participate in Polsky’s Spring 2022 I-Corps Program to Refine Market Fit for Novel Tech Ten teams from across the University of Chicago were selected to participate in the spring 2022 I-Corps program with the goal of determining the commercial potential of their technologies. Supported...
News Inclusive+ Builds Platform to Elevate LGBTQ+ Health Care with Support from the Polsky Accelerator (and a Collaboratorium Assist) As a medical student, Anna Jacobs often encounters LGBTQ+ patients who aren’t getting their health-care needs met. Many are afraid to share information with their providers. Others have providers who...
Technology PMO-Based RNA-Degrading Chimeras For Targeted Degradation Of α-Synuclein mRNA In Neurodegenerative Diseases Phosphorodiamidate morpholino oligomer (PMO)-based RNA-degrading chimeras reduce α-synuclein protein by degrading its messenger RNA preventing protein aggregation and propagation associated with neurodegenerative diseases. The Unmet Need: More potent and selective…
Technology Novel Exosome-Based Drug Delivery For Targeting Alzheimer’s Disease and Cognitive Decline A novel drug delivery system using exosomes derived from hippocampus neuron cells engineered to express the Fe65 protein targeting amyloid-β precursor protein to reduce amyloid plaques Alzheimer's disease. This system…
Technology Nanoparticles Containing Multiple Cleavable Prodrugs For Cancer Therapy Specially designed nanoparticles to deliver multiple cancer drugs at once, improving drug stability, targeting tumors more effectively, and reducing side effects by controlling and triggering drug release directly at the…
